Swiss Nordic Bio

Renaissance Zurich Tower Hotel

Zurich, Switzerland

Thursday 7 February 2019

08:00 - 16:00

The Nordic countries in cooperation with Swiss partners welcome you again to participate in an exclusive investment and partnering meeting. This high-level event gathers Europe’s leading executives from biotech, pharmaceutical, medtech and diagnostics companies as well as investors from Switzerland and the Nordic countries.
Bio Swiss
Photo: Swiss Nordic Bio


Participants in previous years have included: Investors HBM Partners, Bay City Capital, Seventure Partner, HealthCap, Sunstone Capital, NovoSeeds, Capital Rewards Partners, Index Ventures, Creathor Venture, Alden Impact Capital, Occident Group, Redalpine Venture Partners, Johnson & Johnson Innovation, AGIRE Foundation, Industrifonden, Boehringer Ingelheim Venture Fund, PM Equity Partner, XOVenture, Novartis Venture Fund Pharma Roche, Novo Nordisk, Debiopharm, Vifor Pharma, Johnson & Johnson.

Special offer for Gothenburg-based companies

Free of charge for the first 10 Göteborg companies that register. Contact Iris Öhrn to learn more.

Why Swiss Nordic Bio? 

  • Exclusive event (max. 200 people) with a high ratio of investors and pharma to biotech/medtech companies  
  • Gain insight from industry leadersleading industry experts at the Investor and Partnering Panel Discussions 
  • Possibility to pitch and get input on your product and business model from leading investors & pharma and industry peers
  • Discuss your product, business model, and possible collaborations in 1-to-1 meetings with investors & pharma as well as industry peers 
  • Learn more about the possibilities for R&D collaboration between SME, large corporations and academia directly from EUREKA-Eurostars decision-makers

Why Switzerland and the Nordics? 

  • Switzerland and the Nordics are homes of some of the most innovative life science companies globally 
  • Switzerland hosts several leading pharmaceutical companies and life science focused investors 
  • Similarities in technology and R&D standards as well as business culture 
  • Good possibilities for R&D collaboration between SME, large corporations and academia within EUREKA-Eurostars. 


The date for this activity has passed.

Tip a friend